Endothelin and mechanical properties of the carotid artery in Wistar- Kyoto and spontaneously hypertensive rats

Cardiovascular Research

Volumn 41, Issue 3, 1999, Pages 701-707

  Marano, Giuseppe ^a   Grigioni, Mauro ^b   Palazzesi, Sergio ^a   Ferrari, Alberto U ^c  

^a Laboratorio di Farmacologia   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c Ctro Fisiol Clinica e Ipertensione   (Italy)

Author keywords

Arterial distensibility; Endothelin; Spontaneously hypertensive rat; Vascular biology; Wistar Kyoto rat

Indexed keywords

ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL TONE; CAROTID ARTERY; CONTROLLED STUDY; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; BIOMECHANICS; CAROTID ARTERY, COMMON; IMAGE PROCESSING, COMPUTER-ASSISTED; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ENDOTHELIN; VIDEO RECORDING;

EID: 0033066488     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00240-5     Document Type: Article

References (27)

1. Levy B.I., Benessiano J., Poitevin P., Safar M.E. Endothelium-dependent mechanical properties of the carotid artery in WKY and SHR. Role of angiotensin converting enzyme inhibition. Circ Res. 66:1990;321-328.
2. Delacretaz E., Zanchi A., Nussberger J.et al. Chronic nitric oxide synthase inhibition and carotid artery distensibility in renal hypertensive rats. Hypertension. 26:1995;332-336.
3. Lichtenstein O., Safar M.E., Poitevin P., Levy B.I. Biaxial mechanical properties of carotid arteries from normotensive and hypertensive rats. Hypertension. 26:1995;15-19.
4. van Gorp A.W., van Ingen Schenau D.S., Hoecks A.P.G.et al. Aortic wall properties in normotensive and hypertensive rats of various ages in vivo. Hypertension. 26:1995;363-368.
5. Hayoz D., Rutschmann B., Perret F.et al. Conduit artery compliance and distensibility are not necessarily reduced in hypertension. Hypertension. 20:1992;1-6.
6. Laurent S. Arterial wall hypertrophy and stiffness in essential hypertensive patients. Hypertension. 26:1995;355-362.
7. Caputo L., Tedgui A., Levy B.I. Control of carotid vasomotor tone by local renin-angiotensin system in normotensive and spontaneously hypertensive rats. Role of endothelium and flow. Circ Res. 77:1995;303-309.
8. Yanagisawa M., Kurihara H., Kimura S.et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
9. Schiffrin E.L. Endothelin, potential role in hypertension and vascular hypertrophy. Brief review. Hypertension. 25:1995;1135-1143.
10. Haynes W.G., Webb D.J. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet. 344:1994;852-854.
11. Haynes W.G., Ferro C.J., O'Kane K.P.J.et al. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation. 93:1996;1860-1870.
12. Schiffrin E.L., Deng L.Y., Sventek P., Day R. Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension. J Hypertens. 15:1997;57-63.
13. Letizia C., Cerci S., De Toma G.et al. High plasma endothelin-1 levels in hypertensive patients with low-renin essential hypertension. J Hum Hypertens. 11:1997;447-451.
14. Day R., Larivirèe R., Schiffrin E.L. In situ hibridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens. 8:1995;294-300.
15. Schiffrin E.L., Larivirèe R., Li J.-S., Sventek P., Touyz R.M. Deoxycorticosterone acetate plus salt induce overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats. Hypertension. 25:1995;769-773.
16. Masaki T., Vane J.R., Vanhoutte P.M. International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol Rev. 46:1994;137-142.
17. Ikeda S., Awane Y., Kusumoto K.et al. A new endothelin receptor antagonists highly potent for both receptor subtypes ETA and ETB. J Pharmacol Exp Ther. 270:1994;728-733.
18. Awane-Igata Y., Ikeda S., Watanabe T. Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists. Br J Pharmacol. 120:1997;516-522.
19. Macarthur H., Warner T.D., Wood E.G., Corder R., Vane J.R. Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch. Biochem Biophys Res Commun. 200:1994;395-400.
20. Hishikawa K., Nakaki T., Marumo T.et al. Pressure enhances endothelin-1 release from cultured human endothelial cells. Hypertension. 25:1995;449-452.
21. Stella M.L., Mircoli L., Mangoni A.A.et al. Differential alterations of common carotid and femoral artery distensibility in 12-week-old spontaneously hypertensive rats. J Hypertens. 15:1997;1665-1669.
22. Radaelli A, Mircoli L, Mori I, Mancia G, Ferrari AU. Nitric oxide-mediated vasodilation in conscious spontaneously hypertensive rats. Hypertension 1997;30:491(P49).
23. Fujita H., Takeda K., Nakamura K.et al. Role of nitric oxide in impaired coronary circulation and improvement by angiotensin II receptor antagonist in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1:1995;S148-150.
24. Takeshita H., Nishikibe M., Yano M., Ikemoto F. Coronary vascular response to endothelin in isolated perfused hearts of spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 18:1991;661-669.
25. Fuchs L.C., Nuno D., Lamping K.G., Johnson A.K. Characterization of endothelium-dependent vasodilation and vasoconstriction in coronary arteries from spontaneously hypertensive rats. Am J Hypertens. 9:1996;475-483.
26. Tschudi M.R., Lüscher T.F. Age and hypertension differently affect coronary contractions to endothelkin-1, serotonin, and angiotensins. Circulation. 91:1995;2415-2422.
27. Love M.P., Haynes W.G., Gray G.A., Webb D.J., McMurray J.J.V. Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors. Circulation. 94:1996;2131-2137.